Pharmabiz4h
Lupin receives US FDA approval for generic Atrovent nasal spray, 0.06%
Lupin receives US FDA approval for generic Atrovent nasal spray, 0.06%: Our Bureau,Mumbai Tuesday, January 28, 2025, 17:30 Hrs [IST] Global pharma major Lupin Limited (Lupin) anno ...
Pharmabiz3h
WCG introduces ClinSphere Total Enrollment: An all-new participant recruitment and retention SaaS solution for clinical trials
An all-new participant recruitment and retention SaaS solution for clinical trials: Princeton, New Jersey Tuesday, January 28, 2025, 18 ...
Pharmabiz4h
ManipalCigna Health Insurance drives awareness with free health checkup camps
ManipalCigna Health Insurance drives awareness with free health checkup camps: Our Bureau, Bengaluru Tuesday, January 28, 2025, 17:15 Hrs [IST] ManipalCigna Health Insurance in co ...
Pharmabiz4h
Anavex Life Sciences’ Anavex 2-73 to treat neurodegenerative disorders receives US patent
Anavex Life Sciences’ Anavex 2-73 to treat neurodegenerative disorders receives US patent: New York Tuesday, January 28, 2025, 17:00 Hrs [IST] Anavex Life Sciences Corp., a clin ...
Pharmabiz5h
Lupin and Avas launch NaMuscla in Italy to treat myotonia in adults with NDM disorders
Lupin and Avas launch NaMuscla in Italy to treat myotonia in adults with NDM disorders: Our Bureau, Mumbai Tuesday, January 28, 2025, 16:45 Hrs [IST] Global pharma major Lupin Lim ...
Pharmabiz7h
Pfizer’s BREAKWATER trial of Braftovi combo regimen demonstrates improved response in patients with BRAF V600E-mutant metastatic colorectal cancer
Pfizer’s BREAKWATER trial of Braftovi combo regimen demonstrates improved response in patients with BRAF V600E-mutant metastatic colorectal cancer: New York Tuesday, January 28, ...
Pharmabiz5h
Confluence of modern medicine and technology discussed at PIWOT-2025 in Mumbai
Confluence of modern medicine and technology discussed at PIWOT-2025 in Mumbai: Our Bureau, Mumbai Tuesday, January 28, 2025, 16:15 Hrs [IST] Leading experts from healthcare, medi ...
Pharmabiz6h
PureHealth buys majority stake in Hellenic Healthcare Group in USD 2.3 billion transaction
PureHealth buys majority stake in Hellenic Healthcare Group in USD 2.3 billion transaction: Abu Dhabi, UAE Tuesday, January 28, 2025, 15:00 Hrs [IST] PureHealth Holding PJSC, the ...
Pharmabiz5h
Stereotaxis’ MAGiC ablation catheter receives European CE Mark approval
Stereotaxis’ MAGiC ablation catheter receives European CE Mark approval: St. Louis Tuesday, January 28, 2025, 16:00 Hrs [IST] Stereotaxis, a pioneer and global leader in surgica ...
Pharmabiz11h
US FDA grants priority review status to Merck’s sNDA for Welireg to treat patients with advanced pheochromocytoma and paraganglioma
Rahway, New Jersey Tuesday, January 28, 2025, 10:00 Hrs [IST] ...
Pharmabiz12h
AHPI to host intl. conclave on 'Patient-Centred Care: Revolutionizing Hospital Management' in Kochi on Jan 31 & Feb 1
Revolutionizing Hospital Management' in Kochi on Jan 31 & Feb 1: Our Bureau, Bengaluru Tuesday, January 28, 2025, 09:00 Hrs [ ...
Pharmabiz9h
GSK and University of Oxford establish the GSK-Oxford Cancer Immuno-Prevention Programme to advance novel cancer research
GSK plc and the University of Oxford (Oxford) announced that they have entered a new research collaboration focused on the potential of cancer prevention through vaccination. The GSK-Oxford Cancer ...